BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 1636779)

  • 1. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin Activation of Cholecystokinin 1 Receptors: a Purkinje Cell Neuroprotective Pathway.
    Orr HT
    Cerebellum; 2023 Aug; 22(4):756-760. PubMed ID: 35733029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin 1 receptor activation restores normal mTORC1 signaling and is protective to Purkinje cells of SCA mice.
    Wozniak EAL; Chen Z; Paul S; Yang P; Figueroa KP; Friedrich J; Tschumperlin T; Berken M; Ingram M; Henzler C; Pulst SM; Orr HT
    Cell Rep; 2021 Oct; 37(2):109831. PubMed ID: 34644575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.
    Ingram M; Wozniak EAL; Duvick L; Yang R; Bergmann P; Carson R; O'Callaghan B; Zoghbi HY; Henzler C; Orr HT
    Neuron; 2016 Mar; 89(6):1194-1207. PubMed ID: 26948890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
    Desai AJ; Lam PC; Orry A; Abagyan R; Christopoulos A; Sexton PM; Miller LJ
    J Med Chem; 2015 Dec; 58(24):9562-77. PubMed ID: 26654202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for obesity based on gastrointestinal hormones.
    Bagger JI; Christensen M; Knop FK; Vilsbøll T
    Rev Diabet Stud; 2011; 8(3):339-47. PubMed ID: 22262071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowels control brain: gut hormones and obesity.
    Field BC; Chaudhri OB; Bloom SR
    Nat Rev Endocrinol; 2010 Aug; 6(8):444-53. PubMed ID: 20585346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological approaches for the treatment of obesity.
    Fernández-López JA; Remesar X; Foz M; Alemany M
    Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major biological actions of CCK--a critical evaluation of research findings.
    Fink H; Rex A; Voits M; Voigt JP
    Exp Brain Res; 1998 Nov; 123(1-2):77-83. PubMed ID: 9835394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of A71623, a highly selective CCK-A agonist tetrapeptide.
    Asin KE; Bednarz L; Nikkel AL; Gore PA; Montana WE; Cullen MJ; Shiosaki K; Craig R; Nadzan AM
    Am J Physiol; 1992 Jul; 263(1 Pt 2):R125-35. PubMed ID: 1636779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats.
    Asin KE; Gore PA; Bednarz L; Holladay M; Nadzan AM
    Brain Res; 1992 Jan; 571(1):169-74. PubMed ID: 1611492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors.
    Figlewicz DP; Nadzan AM; Sipols AJ; Green PK; Liddle RA; Porte D; Woods SC
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R863-7. PubMed ID: 1415799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.
    Rex A; Barth T; Voigt JP; Domeney AM; Fink H
    Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey.
    Asin KE; Bednarz L; Nikkel AL; Gore PA; Nadzan AM
    Pharmacol Biochem Behav; 1992 Aug; 42(4):699-704. PubMed ID: 1513850
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.